Skip to content

Health Informatics and Resistance Exercise for Symptom Management and Quality of Life in Post-Esophagectomy Patients

Effects of Health Informatics for Symptom Management and Resistance Exercise Strategies on Quality of Life and Sarcopenia in Post-Esophagectomy Patients With Esophageal Cancer: A Mixed-Methods Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07180134
Enrollment
90
Registered
2025-09-18
Start date
2025-10-01
Completion date
2027-07-31
Last updated
2025-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer (EsC), Quality of Life, Sarcopenia

Keywords

Esophagectomy, Nutrition, Quality of life, Exercise

Brief summary

Participants are invited to take part in a research study. In accordance with the requirements of the health authorities, participants must be informed of the purpose of the study and its potential risks. Participation is voluntary, and each participant is free to decide whether or not to enroll. The study may be discussed with trusted individuals, and sufficient time may be taken to consider the decision. If any part of this consent form is unclear, questions may be directed to the principal investigator or the research team, who will provide an explanation. If a participant chooses not to participate, appropriate treatment will still be provided. Even if a participant agrees to participate initially, withdrawal is allowed at any time without affecting medical rights or the care that should be received.

Interventions

BEHAVIORALsymptom management health informatics plus Resistance band exercise training

Access to educational videos and an instant messaging platform for real-time communication, delivered over 12 weeks. plus Structured resistance band exercise, 3 times per week, \ 30 minutes per session, for 12 weeks under research team guidance.

BEHAVIORALUsual Care Group

Standard postoperative nursing care and education routinely provided by the clinical team. No additional interventions will be given.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

the experimental group also received a 12-week intervention consisting of symptom management health informatics and home-based resistance exercise with elastic bands. The health informatics component included educational videos and an instant communication platform addressing common postoperative gastrointestinal symptoms, their mechanisms, and management strategies, such as reflux, dysphagia, dumping syndrome, and delayed gastric emptying. The communication platform enabled two-way interaction, allowing patients to raise concerns and health providers to respond promptly. The resistance exercise program included instructional videos and individualized exercise prescriptions taught before discharge. Patients were instructed to perform band-based resistance exercises at home, avoiding practice within one hour after meals. Each session lasted 40-60 minutes, including warm-up, resistance, and cool-down, performed three times per week for 12 weeks.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Diagnosed with esophageal cancer and having undergone esophagectomy * Postoperative pathological report confirms R0 resection (complete tumor removal) * Able to be discharged after surgery * With or without adjuvant chemoradiotherapy * Clear consciousness and able to communicate in Mandarin or Taiwanese

Exclusion criteria

* Presence of severe cardiovascular disease or psychiatric disorders * Inability to communicate in Mandarin Chinese or Taiwanese * Disease progression during the intervention period that prevents continuation of participation.

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life (EORTC QLQ-C30 score)Baseline, 1 month, 3 months, 6 months after interventionThe European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) is a validated and widely used instrument for assessing quality of life in patients with cancer. It includes five functional scales (physical, role, emotional, cognitive, and social), three symptom scales (fatigue, pain, and nausea/vomiting), a global health status/quality of life scale, and several single-item symptom measures (dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties). Scores are linearly transformed to a 0-100 scale; higher scores on functional and global health scales indicate better functioning/quality of life, whereas higher scores on symptom scales indicate greater symptom burden.

Secondary

MeasureTime frameDescription
Esophageal Cancer-related Symptoms (EORTC QLQ-OES18 score)1 month, 3 months, 6 months after interventionThe EORTC QLQ-OES18 is a validated disease-specific module designed to assess esophageal cancer-related symptoms and treatment side effects. It includes 18 items covering dysphagia, eating restrictions, reflux, pain, trouble swallowing saliva, choking when swallowing, dry mouth, taste problems, cough, and speech difficulties. Each item is scored on a 4-point Likert scale and linearly transformed to a 0-100 scale, with higher scores indicating greater symptom burden.
Sarcopenia Status (e.g., SARC-F or handgrip strength, muscle mass index)Baseline, 1 month, 3 months, 6 months after interventionSarcopenia risk will be assessed using the SARC-F questionnaire, which evaluates strength, assistance with walking, rising from a chair, climbing stairs, and falls. Each item is scored 0-2, with a total score ranging from 0 to 10. A score ≥4 indicates risk of sarcopenia.
Body Mass Index (BMI)Baseline, 1 month, 3 months, 6 months after interventionBody mass index (BMI) will be calculated as weight in kilograms divided by height in meters squared (kg/m²). Weight will be measured using a calibrated digital scale, and height will be measured with a stadiometer at baseline. Changes in BMI will be assessed at follow-up visits. Lower BMI values after surgery may indicate postoperative weight loss or malnutrition.

Contacts

Primary ContactYULING CHANG
witchchange@gmail.com886+966572613

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026